Email this article 
PRIMENENIE KOMBINIROVANNYKh ORAL'NYKh KONTRATsEPTIVOV, SODERZhAShchIKh DROSPIRENON, PRI LEChENII SINDROMA POLIKISTOZNYKh YaIChNIKOV
- Authors: Raykova A.A 1
- Affiliations:
- Issue: Vol 3, No 4 (2016)
- Pages: 214-215
- Section: Original papers
- URL: https://journals.eco-vector.com/2313-8726/article/view/35393
- Cite item
Open Access
Access granted
Abstract
Polycystic ovary syndrome is one of the most studied pathologies in gynecology, but the etiology and pathogenesis has not been fully elucidated. An important role in the treatment of combined oral contraceptives play a latest-generation progestogen, such as drospirenone. The use of combined oral contraceptives with antiandrogen activity justified pathogenetically.
Full Text
